Online Ratings Not Aligned With Objective Quality Measures

Share this content:
Online Ratings Not Aligned With Objective Quality Measures
Online Ratings Not Aligned With Objective Quality Measures

MONDAY, Oct. 16, 2017 (HealthDay News) -- Online consumer ratings of specialist physicians do not predict objective measures of quality of care or peer assessment of clinical performance, according to a study published online Sept. 8 in the Journal of the American Medical Informatics Association.

Timothy J. Daskivich, M.D., M.S.H.P.M., from Cedars-Sinai Medical Center in Los Angeles, and colleagues compared consumer ratings with specialty-specific performance scores (metrics including adherence to Choosing Wisely measures, 30-day readmissions, length of stay, and adjusted cost of care), primary care physician peer-review scores, and administrator peer-review scores for 78 physicians representing eight medical and surgical specialties.

The researchers found that across ratings platforms, there was no significant association between mean consumer ratings and specialty-specific performance scores, primary care physician scores, or administrator scores. There was also no association between ratings and score subdomains related to quality or value-based care. For physicians in the lowest quartile of specialty-specific performance scores, only 5 percent to 32 percent had consumer ratings in the lowest quartile across platforms. Ratings were consistent across platforms, with a physician's score on one platform significantly predicting his/her score on another in five of 10 comparisons.

"Online consumer ratings should not be used in isolation to select physicians, given their poor association with clinical performance," conclude the authors.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »